Gut-Skin Axis

Rosacea and gut health: what the research on SIBO and gut bacteria shows

Hussain Abdeh, Pharmacist
Written by Hussain Abdeh, MPharm Published 26 October 2026
Sonia Khan, Pharmacist
Medically reviewed by Sonia Khan, Pharmacist Last reviewed 26 October 2026

Rosacea and gut health are linked in several studies. People with rosacea are more likely than people without it to have a number of gut conditions, and the most studied link of all is with small intestinal bacterial overgrowth, usually shortened to SIBO. These are associations. None of the research shows that the gut causes rosacea, and no treatment aimed at the gut is part of standard rosacea care on the NHS. Rosacea itself is a long-term inflammatory skin condition, driven by an over-reactive immune and nerve response in facial skin, with genes, sun exposure and a skin mite called Demodex all contributing. This guide covers the SIBO research and its weaknesses, the wider gut associations, the Helicobacter pylori question, what the rosacea dose of doxycycline does to the gut, and what a gut microbiome test can and cannot tell you. Our guide to the gut-skin axis explains how the gut can reach the skin at all.

Is rosacea linked to gut health?

The strongest numbers come from Denmark. A 2017 registry study compared the health records of 49,475 people with rosacea against more than four million without it. Coeliac disease, Crohn's disease, ulcerative colitis and irritable bowel syndrome were all diagnosed more often in the rosacea group, with the raised risk sitting between roughly 20 and 50 percent depending on the condition.

A record study of this size can show that two conditions appear together more often than chance would predict. It cannot show that one causes the other, and it cannot rule out a shared cause, such as genes or a general tendency to inflammation, driving both. What it does support is taking gut symptoms seriously in their own right. If you have rosacea and ongoing digestive problems, mention both to your GP rather than assuming they are unrelated.

What does the research show about rosacea and SIBO?

SIBO stands for small intestinal bacterial overgrowth. The small intestine normally holds far fewer bacteria than the colon, and in SIBO that balance tips, which can cause bloating, wind, discomfort and loose stools. In a 2008 Italian study, 113 people with rosacea and 60 people without took breath tests for SIBO. In the rosacea group, 52 of the 113 tested positive, against 3 of the 60 without rosacea.

The same team then treated the overgrowth. People who had tested positive received rifaximin, an antibiotic that stays in the gut, or a placebo. Where the overgrowth cleared, the rosacea cleared or improved markedly in most cases, while the placebo group stayed the same or got worse. In people who had tested negative, the same antibiotic made almost no difference to the skin. A follow-up study by the same group reported that most treated patients were still in remission three years later.

Those results have not been matched since, and they carry real weaknesses. The dermatologists scoring the skin knew who had received the antibiotic, which tends to bias results in a treatment's favour. Breath tests measure the overgrowth indirectly, and the American College of Gastroenterology's guideline on SIBO notes that they can return false positives, the lactulose version in particular, which was one of the two tests the Italian team used. The Danish registry study, with far larger numbers, found no SIBO association at all.

Pooling everything available still leaves a gap between the groups. A 2025 pooled analysis of the six studies ever run, 801 people in all, found that around a third of people with rosacea tested positive for SIBO against roughly one in ten people without. The breath-test weakness runs through every included study, and the 2008 Italian results are the largest single contribution. In a 2025 UK study of 731 people referred for breath testing, those who reported rosacea were slightly more likely to test positive, a difference small enough to have been chance.

Breath testing for SIBO is not a routine NHS investigation for rosacea, and rifaximin is not part of rosacea care in the UK. If you have persistent bloating, loose stools or stomach discomfort alongside rosacea, see your GP about the gut symptoms in their own right.

Is H. pylori linked to rosacea?

Helicobacter pylori, a stomach bacterium best known for causing ulcers, has been studied in rosacea for three decades, and the results still disagree. A 2017 meta-analysis of 14 studies found people with rosacea were somewhat more likely to carry the infection, but the overall difference fell just short of statistical significance, and treating the infection did not clearly improve the skin. A 2024 meta-analysis pooling 23 studies did find a link, but the included studies disagreed with each other substantially, and in the analyses built on whole-population prescription records the link disappeared.

The evidence here is mixed. If H. pylori contributes to rosacea at all, the effect looks small, and clearing the infection is not a recognised rosacea treatment. The infection does cause stomach and duodenal ulcers, so persistent upper stomach pain, especially with black stools or unexplained weight loss, needs a GP appointment regardless of your skin.

What have gut microbiome studies found in rosacea?

Very little sequencing research exists. A study in Korea compared stool samples from 12 women with rosacea against 251 without and found differences in several groups of bacteria. A study in Taiwan compared 11 people with rosacea against 110 matched controls and found a less varied gut microbiome overall. Twelve and eleven people are very small numbers for microbiome research, and the two studies did not find the same changes.

A systematic review that searched for every gut sequencing study in rosacea found a total of 23 patients ever studied, and described the results as inconsistent and in places contradictory.

That is far thinner than the research in other skin conditions. Dozens of studies have compared gut bacteria in people with and without eczema, and our guide to gut bacteria differences in eczema covers them. The early studies in acne also point in a broadly consistent direction. In rosacea, the gut microbiome question remains close to unanswered.

Does doxycycline for rosacea affect your gut?

Doxycycline for rosacea is not one single treatment. In the UK it is often prescribed as a 40mg modified-release capsule, a dose set deliberately low to act on inflammation rather than to kill bacteria, and some people take it at the standard antibiotic dose instead. What it does to the gut depends on which was prescribed. A standard antibiotic course of doxycycline changes the mix of bacteria in the gut, as any oral antibiotic does. Whether the low dose does the same has never been properly measured, and a randomised trial now under way in the United States is comparing the low dose, the full dose and a placebo to settle that question, including what each does to gut bacteria. Until it reports, the low dose is assumed to be gentler on the gut, not proven to be. Our guide to how antibiotics change the gut microbiome covers what a standard course does and how the gut recovers.

If you are taking doxycycline for rosacea, keep taking it as prescribed. It is prescribed because it works, and stopping early risks the rosacea flaring back. Take any questions about the course and your gut to the prescriber or a pharmacist.

Can a gut microbiome test help with rosacea?

A gut microbiome test cannot diagnose rosacea, cannot detect SIBO, and cannot tell you that your gut is behind your flushing or spots. Rosacea is diagnosed by a clinician looking at your skin. SIBO is assessed with breath tests arranged by a doctor, because it involves the small intestine, which a stool sample does not represent. And the sequencing research above is too thin to have defined any gut signature for rosacea.

A stool-based test does measure the large-intestine side of the picture. It shows which bacteria live in your colon, how diverse that community is, and whether any of the groups studied in rosacea are scarce or overrepresented. Our test reads the bacterial DNA in a stool sample and sets your results against published research on skin conditions, so the report shows where your profile resembles patterns from that research, and nothing in it amounts to a diagnosis. Our page on gut microbiome testing for rosacea sets out what the test measures and what the report covers for skin-related markers.

Is rosacea a gut issue?

Not on current evidence. Rosacea is a skin condition with gut associations, which is different from a gut condition showing on the face. The one trial in which treating the gut improved rosacea is the 2008 SIBO study, it applies only to people who tested positive for an overgrowth, and the skin scoring in it was not blinded. Beyond that trial, no study has shown that changing the gut improves rosacea.

Supplements containing live bacteria have barely been tested in this condition. A 2025 review of diet and gut-directed approaches in rosacea found early positive reports and no well-controlled trial behind any of them. No diet has been shown to treat rosacea either. The familiar trigger advice, cutting down alcohol, spicy food and hot drinks, comes from people tracking their own flare-ups rather than from gut research, and it costs nothing to try. Cutting out whole food groups in the hope of calming your skin has no evidence behind it and real downsides, so discuss any bigger dietary change with a GP or registered dietitian first.

When should you see a GP about rosacea?

Rosacea is diagnosed by sight. There is no blood test or scan for it, and no gut test plays any part. A GP can usually recognise it in one appointment, and NHS treatment works well for most people, from prescription creams and gels such as ivermectin, metronidazole and azelaic acid through to doxycycline capsules for more inflamed skin, with referral to a dermatologist if those fail.

See a GP promptly if your eyes are affected. Gritty, sore, red or light-sensitive eyes alongside facial redness can be ocular rosacea, which needs treatment in its own right, and any eye pain or change in your vision needs same-day advice. Book an appointment too if facial redness is new and persistent, because other conditions, including lupus, can look similar at first, if the skin on your nose is thickening, or if flushing comes with sweating, headaches or a racing heart, which points away from rosacea. Nothing in the gut research is a reason to delay seeing a GP, and no prescribed rosacea treatment should be stopped because of anything a gut test shows.

This guide is for information only and does not replace medical advice. Speak to your GP or pharmacist about your own symptoms.

Sources

  • Egeberg A, Weinstock LB, Thyssen EP, et al. (2017). Rosacea and gastrointestinal disorders: a population-based cohort study. British Journal of Dermatology. PubMed | DOI
  • Parodi A, Paolino S, Greco A, et al. (2008). Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clinical Gastroenterology and Hepatology. PubMed | DOI
  • Agnoletti AF, De Col E, Parodi A, et al. (2016). Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. Giornale Italiano di Dermatologia e Venereologia. PubMed | DOI
  • Pimentel M, Saad RJ, Long MD, Rao SSC (2020). ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. The American Journal of Gastroenterology. PubMed | DOI
  • Khurmatullina AR, Kucheryavyy YA, Andreev DN, et al. (2025). Prevalence and risk of small intestinal bacterial overgrowth in patients with rosacea: a systematic review and meta-analysis. Terapevticheskii Arkhiv. PubMed | DOI
  • Haworth JJ, Treadway S, Bloor S, et al. (2025). Can Symptoms and Medical History Predict Outcomes for Hydrogen and Methane Breath Testing? The American Journal of Gastroenterology. PubMed | DOI
  • Jørgensen AHR, Egeberg A, Gideonsson R, et al. (2017). Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. PubMed | DOI
  • Gao Y, Yang XJ, Zhu Y, et al. (2024). Association between rosacea and helicobacter pylori infection: A meta-analysis. PLoS One. PubMed | DOI
  • Nam JH, Yun Y, Kim HS, et al. (2018). Rosacea and its association with enteral microbiota in Korean females. Experimental Dermatology. PubMed | DOI
  • Chen YJ, Lee WH, Ho HJ, et al. (2021). An altered fecal microbial profiling in rosacea patients compared to matched controls. Journal of the Formosan Medical Association. PubMed | DOI
  • Tutka K, Żychowska M, Reich A (2020). Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea-A Systematic Review of the Literature. Microorganisms. PubMed | DOI
  • Mahmud H, Keenan JD, Gonzales J, et al. (2022). Ocular Rosacea microBiome Study (ORBS)-sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial. Trials. PubMed | DOI
  • Manfredini M, Barbieri M, Milandri M, Longo C (2025). Probiotics and Diet in Rosacea: Current Evidence and Future Perspectives. Biomolecules. PubMed | DOI

Reading next